Poly(ionic liquid) Electrolytes for a Switchable Silver Mirror by Xiao Hou (3228048)

“…These findings were used to guide fabrication of a 50 cm² mirror dynamic window and flexible display. …”

DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet2_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet3_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet1_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet6_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

DataSheet4_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Data_Sheet_1_Propofol EC50 for inducing loss of consciousness in patients under combined epidural-general anesthesia or general anesthesia alone: a randomized double-blind study.do... by Jiangling Wang (11929476)

“…</p>Conclusion<p>Concomitant epidural anesthesia reduced by 15% the EC₅₀ of predicted Ce_prop for LOC, decreased the consumptions of propofol and remifentanil during maintenance of anesthesia, and fastened recovery from anesthesia.…”

Example for a parametrically manipulated baby. by Sarah K. C. Holtfrerich (3353693)

Fig 5 - by Hyun-Jun Kim (1561153)

C/EBPα binds five sites within the <i>Cebpa</i> +8 kb enhancer. by Lei Peng (260321)

Fig 3 - by Hyun-Jun Kim (1561153)

Fig 5 - by Pieter J. K. Aukes (11105259)

Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells by Tadeja Kuret (5059433)

“…<div><p>Serum amyloid A (SAA) is a sensitive inflammatory marker rapidly increased in response to infection, injury or trauma during the acute phase. …”

Fig 1 - by Hyun-Jun Kim (1561153)

“…<p>A) Chemical structure of Ni. B) Representative crystal violet assay for C2C12 myoblasts treated with Ni for 48 h (IC₅₀ = 2.11 μM). …”

Rec12-DNA Covalent Linkages Are Readily Detectable in <i>rad50⁺</i> Strains. by Randy W. Hyppa (269310)

“…The 5 h <i>rad50S</i> DNA shows a much stronger enrichment (ratio of PCR product from the ChIP to that from the WCE) as a result of Rec12 not being removed from the DNA ends in that strain. …”

Sequential viral infection is associated with reduced antibody response to intramuscular and intranasal ChAd-SARS-CoV-2 vaccination. by Yuhao Li (1559569)

Fig 4 - by Maria Alice Miranda Bezerra Medeiros (11752002)

Quantification of blood ACE levels in carriers of ACE mutations. by Olga V. Kryukova (19819428)

Effects of anti-TNF-α treatment on insulin sensitivity in skeletal muscle after FTox-G50 injection. by Aouatef Ait-Lounis (151054)

“…(C) Schematic diagram of decreased glucose uptake in skeletal muscle after FTox-G50 injection; up and down arrows indicate increased and decreased expression, respectively.…”